Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: A randomized open-label prospective trial-Reference-Cited by-同舟云学术

Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: A randomized open-label prospective trial

Published:2016-06 Issue: Volume:116 Page:244-252
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Abe Masanori,Higuchi Terumi,Moriuchi Masari,Okamura Masahiro,Tei Ritsukou,Nagura Chinami,Takashima Hiroyuki,Kikuchi Fumito,Tomita Hyoe,Okada Kazuyoshi

Funder

Kyowa Hakko Kirin Co. Ltd.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference21 articles.

1. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice;Abe;Curr Drug Metab,2011

2. Haemodialysis-induced hypoglycaemia and glycaemic disarrays;Abe;Nat Rev Nephrol,2015

3. Efficacy and safety of mitiglinide in diabetic patients on maintenance hemodialysis;Abe;Endocr J,2010

4. Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis;Abe;Expert Opin Pharmacother,2010

5. Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease;Kidney Disease Outcomes Quality Initiative ((KDOQI));Am J Kidney Dis,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rubrometabolic Syndrome;Minerva Endocrinology;2023-03

2. Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials;Frontiers in Endocrinology;2022-10-24

3. 3．糖尿病（diabetes mellitus：DM）;Nihon Toseki Igakkai Zasshi;2022

4. Insulin therapy in diabetic kidney disease;Diabetic Nephropathy;2021-09-01

5. Efficacy of combined angiotensin II receptor blocker with tripterygium glycosides on diabetic nephropathy;Medicine;2021-06-04